pharmaphorum Podcast
pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.
Listen on:
Episodes
Monday Jun 06, 2022
Monday Jun 06, 2022
In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock catches up with Pervaise Khan, Managing Director of Life Sciences, UK and Ireland, Accenture.
Thursday May 19, 2022
Thursday May 19, 2022
In the newest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Mohammed Issa, Vice President of Commercial at US Janssen Neuroscience.
Friday Apr 29, 2022
Friday Apr 29, 2022
In the newest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Dr Colin Banas, chief medical officer at DrFirst.
They discuss out of control drug pricing, especially in the United States, that has led to nonadherence and care rationing
Wednesday Mar 23, 2022
Wednesday Mar 23, 2022
In the latest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Miruna Sasu, chief strategy officer of COTA and long-time pharma vet - before joining COTA last year, she headed up J&J’s Clinical Trial Feasibility and Advanced Analytics Team and led the Digital Health and Innovation Team at Bristol Myers Squibb.
Thursday Feb 10, 2022
Thursday Feb 10, 2022
In the latest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Jennifer Goldsack, CEO of the Digital Medicine Society (DiMe).
Tune in to hear about the year ahead in digital health and life sciences, as well as the need for partnership and collaboration more broadly between the pharma and tech worlds. Goldsack reports on what she heard in the virtual events surrounding JP Morgan this year, and then puts some of those insights into context out of her own experience.
Friday Jan 14, 2022
Friday Jan 14, 2022
In the latest episode of the pharmaphorum podcast, Dr Paul Tunnah speaks to head of Patient Engagement at Syneos Health, Marie Emms, and Elligo Health Research vice president, strategic partnerships, Keith Fern.
Together they discuss the changing nature of clinical trials how COVID-19 impacted the sector, and the role technology is playing in supporting trial enrolment and retention.
Friday Dec 17, 2021
Friday Dec 17, 2021
This episode of the pharmaphorum podcast is the second in a limited series focused on patient engagement that’s being led clinician, consultant and patient advocate, Mark Duman.
Thursday Nov 25, 2021
Thursday Nov 25, 2021
In the first episode of the ELICIT podcast, a new series produced in partnership with Cerner Enviza, the guests discuss qualitative real-world evidence and a unique dementia project from Singapore.
Friday Nov 12, 2021
Friday Nov 12, 2021
Episode 45 of the pharmaphorum podcast heard from Dr Stuart Hill, how he’s seen the oncology landscape change and which of those he sees holding the most potential to improve patient outcomes.
Friday Nov 05, 2021
Friday Nov 05, 2021
In the latest episode of the podcast Dominic Tyer speaks with Pierre Bourdage, who’s global head of biopharmaceuticals at Sandoz about the big issues in biosimilars.